The standardized mortality rate for genitourinary system diseases among Canadian women is forecasted to steadily decline from 2024 through 2028, starting at 12.6 per 100,000 women in 2024 and decreasing to 12.3 by 2028. This forecasted trend reflects a subtle year-on-year decrease, suggesting a gradual improvement in health outcomes or healthcare interventions. Notably, the rate stood at an approximate value in 2023, and the data from 2024 are projections based on current trends. The compound annual growth rate (CAGR) over these five years denotes a declining trend.
Future trends to watch for include:
- Advancements in medical technology and treatment protocols that may further lower mortality rates.
- Public health initiatives focusing on early detection and prevention.
- Potential demographic shifts that could impact disease incidence and mortality.
